锦波生物
(832982)
| 流通市值：220.23亿 | | | 总市值：424.77亿 |
| 流通股本：4589.11万 | | | 总股本：8851.18万 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 958,678,503.23 | 941,124,763.4 | 812,408,426.94 | 702,492,000.29 |
| 应收票据及应收账款 | 169,525,276.77 | 189,452,905.91 | 154,067,086.36 | 124,741,916.23 |
| 其中：应收票据 | 15,393,000 | 5,835,000 | 329,441.78 | 4,568,000 |
| 应收账款 | 154,132,276.77 | 183,617,905.91 | 153,737,644.58 | 120,173,916.23 |
| 应收款项融资 | 23,450,000 | 5,139,000 | 82,938.22 | 6,852,000 |
| 预付款项 | 43,112,092.7 | 38,149,612.05 | 39,068,200.02 | 24,735,801.26 |
| 其他应收款合计 | 7,984,389.09 | 9,052,787.52 | 6,680,051.2 | 5,204,639.95 |
| 存货 | 117,791,431.68 | 96,567,880.45 | 86,516,611.68 | 70,682,169.6 |
| 其他流动资产 | 9,891,894.55 | 18,120,974.31 | 16,799,527.39 | 20,083,316.05 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,330,433,588.02 | 1,297,607,923.64 | 1,115,622,841.81 | 954,791,843.38 |
| 非流动资产: | | | | |
| 长期股权投资 | - | - | - | 0 |
| 固定资产 | 449,648,127.59 | 460,452,397.97 | 472,450,602.33 | 475,603,531.4 |
| 在建工程 | 141,432,529.28 | 19,373,344.59 | 9,906,145.52 | 10,097,615.33 |
| 使用权资产 | 86,823,582.58 | 90,668,025.91 | 90,920,687.26 | 88,613,534.52 |
| 无形资产 | 120,579,766.03 | 22,534,870.15 | 22,417,402.8 | 22,875,909.54 |
| 开发支出 | 73,615,602.43 | 69,941,527.85 | 64,946,514.75 | 61,590,288.25 |
| 长期待摊费用 | 18,754,117.03 | 19,436,340.05 | 18,103,750.85 | 19,127,916.3 |
| 递延所得税资产 | 14,976,479.99 | 14,666,317.02 | 14,182,675.48 | 14,099,913.15 |
| 其他非流动资产 | 23,098,206.84 | 61,392,669.8 | 41,359,079.5 | 18,545,782.75 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 928,928,411.77 | 758,465,493.34 | 734,286,858.49 | 710,554,491.24 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,259,361,999.79 | 2,056,073,416.98 | 1,849,909,700.3 | 1,665,346,334.62 |
| 流动负债: | | | | |
| 短期借款 | - | - | 29,984,336.77 | 44,403,652.76 |
| 应付票据及应付账款 | 91,389,278.91 | 51,533,951.96 | 62,190,277.48 | 58,570,128.14 |
| 应付账款 | 91,389,278.91 | 51,533,951.96 | 62,190,277.48 | 58,570,128.14 |
| 合同负债 | 49,541,123.53 | 42,588,204.89 | 41,320,291.32 | 39,777,498.27 |
| 应付职工薪酬 | 31,669,296.88 | 49,787,597.02 | 26,313,913.89 | 24,468,655.62 |
| 应交税费 | 62,024,074.01 | 52,299,445.28 | 49,118,634.75 | 43,981,798.93 |
| 其他应付款合计 | 27,620,299.03 | 25,463,945.85 | 24,910,180.7 | 21,848,008.82 |
| 一年内到期的非流动负债 | 59,427,489.67 | 63,847,868.24 | 67,126,704.08 | 63,060,445.81 |
| 其他流动负债 | 9,636,412.58 | 6,637,891.26 | 1,441,994.84 | 1,379,462.17 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 331,307,974.61 | 292,158,904.5 | 302,406,333.83 | 297,489,650.52 |
| 非流动负债: | | | | |
| 长期借款 | 76,069,471.54 | 79,588,411.52 | 79,526,623.52 | 19,845,788.49 |
| 租赁负债 | 93,088,926.06 | 93,475,341.14 | 89,737,120.79 | 86,465,852.86 |
| 递延收益 | 52,135,867.93 | 53,199,535.77 | 55,265,268.11 | 60,370,744.3 |
| 递延所得税负债 | 1,370,876.75 | 1,443,287.53 | 1,515,698.31 | 1,588,109.09 |
| 其他非流动负债 | 5,000,000 | 5,000,000 | 5,000,000 | 5,000,000 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 227,665,142.28 | 232,706,575.96 | 231,044,710.73 | 173,270,494.74 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 558,973,116.89 | 524,865,480.46 | 533,451,044.56 | 470,760,145.26 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 88,511,800 | 88,511,800 | 88,511,800 | 88,511,800 |
| 资本公积 | 316,242,811.29 | 316,242,811.29 | 310,406,159.4 | 310,406,159.4 |
| 盈余公积 | 44,255,900 | 44,255,900 | 44,255,900 | 44,255,900 |
| 未分配利润 | 1,254,733,715.17 | 1,086,203,317.13 | 873,850,314.35 | 751,977,600.51 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,703,744,226.46 | 1,535,213,828.42 | 1,317,024,173.75 | 1,195,151,459.91 |
| 少数股东权益 | -3,355,343.56 | -4,005,891.9 | -565,518.01 | -565,270.55 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,700,388,882.9 | 1,531,207,936.52 | 1,316,458,655.74 | 1,194,586,189.36 |
| 负债和股东权益合计 | 2,259,361,999.79 | 2,056,073,416.98 | 1,849,909,700.3 | 1,665,346,334.62 |
| 公告日期 | 2025-04-22 | 2025-04-21 | 2024-10-21 | 2024-08-22 |
| 审计意见(境内) | | 标准无保留意见 | | |